MedPath

KEYTRUDA

KEYTRUDA

Approved
DIN Number

02456869

Drug Class

Human

Market Date

Jul 13, 2017

Company
HC

Merck Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02456869
AIG Number0156910003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01FF02 PEMBROLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PEMBROLIZUMABActive
Strength: 25 MG / ML
Monograph: PEMBROLIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.